Drug Trial Radar · NCT06540144
An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
13
Actual
Start
Oct 8, 2024
Primary completion
Oct 5, 2027
Study completion Oct 5, 2027
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Aug 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the long term safety and tolerability of additional 6-week treatment cycles with rozanolixizumab in pediatric participants with generalized Myasthenia Gravis (gMG) aged ≥2 at the time of the Screening Visit of MG0006.
Conditions
- Generalized Myasthenia Gravis
Interventions
rozanolixizumabDrug
rozanolixizumab solution for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of serious Treatment-Emergent Adverse Events (TEAEs) up to the End of Study (EOS) VisitTime frame: From Baseline up to the EOS Visit (up to 52 weeks)
- Occurrence of TEAEs leading to permanent withdrawal of IMP up to the EOS VisitTime frame: From Baseline up to the EOS Visit (up to 52 weeks)
- Occurrence of Adverse Event(s) of Special Monitoring (AESM) up to the EOS VisitTime frame: From Baseline up to the EOS Visit (up to 52 weeks)
Locations
9 sites in 4 countries. Site status is shown where the registry gives one.
Mg0008 40290
Bologna, Italy
Mg0008 40144
Milan, Italy
Mg0008 40733
Naples, Italy
Mg0008 20340
Fuchu-shi, Japan
Mg0008 20339
Ōbu, Japan
Mg0008 20343
Sagamihara, Japan
Mg0008 40734
Lodz, Poland
Mg0008 40155
Warsaw, Poland
Mg0008 40841
Yenimahalle, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.